Insider · CIK 0002074268
Dalia Nadine Asterbadi
Files at MUX (McEwen Inc.). First filing -, latest -.
Dalia Nadine Asterbadi files SEC Form 4 as director at MUX (McEwen Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Dalia Nadine Asterbadi has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | MUX McEwen Inc. | AGrant or award Deferred Stock Unitsderivative | +479 | $0.00 | $0 | 1,790 | Mar 23, 2026 |
| Nov 10, 2025 | MUX McEwen Inc. | AGrant or award Deferred Stock Unitsderivative | +585 | $0.00 | $0 | 1,311 | Nov 12, 2025 |
| Sep 8, 2025 | MUX McEwen Inc. | AGrant or award Deferred Stock Unitsderivative | +726 | $0.00 | $0 | 726 | Sep 10, 2025 |
| Aug 11, 2025 | MUX McEwen Inc. | AGrant or award Stock Option (right to buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Aug 13, 2025 |
Questions about Dalia Nadine Asterbadi
Answered from the filings on this page, as of the latest one.
Is Dalia Nadine Asterbadi buying or selling?
Dalia Nadine Asterbadi has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Dalia Nadine Asterbadi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dalia Nadine Asterbadi has 0.
Where does Dalia Nadine Asterbadi file Form 4?
Dalia Nadine Asterbadi has filed Form 4 at MUX (McEwen Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.